Enda McVeigh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Enda McVeigh has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
A Slack
Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK
1 shared publicationC Cunningham
Nuffield Department of Obstetrics and Gynaecology and b Department of Colorectal Surgery, John Radcliffe Hospital, Oxford, UK
1 shared publicationI Lindsey
Nuffield Department of Obstetrics and Gynaecology and b Department of Colorectal Surgery, John Radcliffe Hospital, Oxford, UK
1 shared publication- Lee Nai Lim
Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU, UK
1 shared publication - Monica Mittal
Department of Obstetrics and Gynecology, Imperial College Healthcare NHS Trust, St Mary's and Hammersmith Hospitals, London, UK
1 shared publication N Mortensen
Nuffield Department of Obstetrics and Gynaecology and b Department of Colorectal Surgery, John Radcliffe Hospital, Oxford, UK
1 shared publication
Latest Publications
- Open Access
- 27 February 2018
- Published by Springer Nature in Reproductive Health
- Vol. 15 (1) , 1-15
The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence
Public funding for fertility services within the United Kingdom is limited, and therefore, strict guidance exists regarding who can be offered treatment under the National Health Service (NHS). Body mass index (BMI) is a universal criteria adopted by both the public and private sector. This study addresses an important aspect of the impact of a raised BMI on fertility treatment outcomes. We standardise the analysis of the data by only including studies incorporating the WHO BMI criteria; the current reference point for clinicians and clinical commissioning groups in ascertaining which group of patients should receive treatment. This study is an update of the previous systematic review performed in 2010, with the inclusion of a larger number of cycles from central databases such as the Society for Assisted Reproductive Technology (SART). An electronic literature search was conducted through the Cochrane, Medline and Embase libraries. Data extraction for each outcome measure was pooled and expressed as an odds ratio with 95% confidence intervals. Where clinical heterogeneity was evident, the random effects model was used to calculate the risk ratio and a fixed effects model was used for the remaining studies. A p value < 0.05 was considered statistically significant. A total of 49 studies have been identified and included in this systematic review. Overweight and obese (BMI ≥ 25 kg/m2) women have a statistically significant lower live birth rate (OR 0.81, 95% CI 0.74–0.89, p < 0.00001) following Assisted Reproductive Technology (ART) when comparisons are drawn to women with a normal BMI. An increase is also demonstrated in the number of miscarriages experienced by women with a BMI ≥ 30 kg/m2 (OR 1.52, 95% CI 1.28–1.81, p < 0.00001). Although this review concludes that a clear impact of BMI on ART outcomes is demonstrated, there remains questions as to the pathophysiology underlying these differences. This review supports the government’s stringent criteria regarding BMI categories under which NHS funding is made available for ART, through a clear description of poor reproductive outcomes in women with a BMI ≥ 30 kg/m2.
- 27 February 2018
- Published by Springer Nature in Reproductive Health
- Vol. 15 (1) , 1-15
Open AccessThe correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence
Public funding for fertility services within the United Kingdom is limited, and therefore, strict guidance exists regarding who can be offered treatment under the National Health Service (NHS). Body mass index (BMI) is a universal criteria adopted by both the public and private sector. This study addresses an important aspect of the impact of a raised BMI on fertility treatment outcomes. We standardise the analysis of the data by only including studies incorporating the WHO BMI criteria; the current reference point for clinicians and clinical commissioning groups in ascertaining which group of patients should receive treatment. This study is an update of the previous systematic review performed in 2010, with the inclusion of a larger number of cycles from central databases such as the Society for Assisted Reproductive Technology (SART). An electronic literature search was conducted through the Cochrane, Medline and Embase libraries. Data extraction for each outcome measure was pooled and expressed as an odds ratio with 95% confidence intervals. Where clinical heterogeneity was evident, the random effects model was used to calculate the risk ratio and a fixed effects model was used for the remaining studies. A p value < 0.05 was considered statistically significant. A total of 49 studies have been identified and included in this systematic review. Overweight and obese (BMI ≥ 25 kg/m2) women have a statistically significant lower live birth rate (OR 0.81, 95% CI 0.74–0.89, p < 0.00001) following Assisted Reproductive Technology (ART) when comparisons are drawn to women with a normal BMI. An increase is also demonstrated in the number of miscarriages experienced by women with a BMI ≥ 30 kg/m2 (OR 1.52, 95% CI 1.28–1.81, p < 0.00001). Although this review concludes that a clear impact of BMI on ART outcomes is demonstrated, there remains questions as to the pathophysiology underlying these differences. This review supports the government’s stringent criteria regarding BMI categories under which NHS funding is made available for ART, through a clear description of poor reproductive outcomes in women with a BMI ≥ 30 kg/m2.
- Open Access
- 12 September 2007
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 114 (10) , 1278-1282
Urological and colorectal complications following surgery for rectovaginal endometriosis
Objectives To report the short‐ and medium‐term complications of laparoscopic laser excisional surgery for rectovaginal endometriosis.Design Retrospective cohort study.Setting University teaching hospital, UK.Population A total of 128 women with histologically confirmed rectovaginal endometriosis who underwent laparoscopic laser surgery between May 1999 and September 2006.Methods Women were identified from operative database, and a case note review was performed. Data for surgical outcome and surgical complications were collected.Main outcome measures Rates of urinary tract and colorectal complications.Results A total of 128 women underwent surgery. Of these, 32 required intraoperative closure of a rectal wall defect, including 3 segmental rectosigmoid resections. There were three rectovaginal fistulae and one ureterovaginal fistula. Ureteric damage occurred in two women, and five women suffered postoperative urinary retention. The risk of intraoperative bowel intervention was increased in women who complained of cyclical rectal bleeding.Conclusion Laparoscopic laser excision of rectovaginal endometriosis is a safe procedure with similar, if not lower, complication rates to other published surgical series.
- 12 September 2007
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 114 (10) , 1278-1282
Open AccessUrological and colorectal complications following surgery for rectovaginal endometriosis
Objectives To report the short‐ and medium‐term complications of laparoscopic laser excisional surgery for rectovaginal endometriosis.Design Retrospective cohort study.Setting University teaching hospital, UK.Population A total of 128 women with histologically confirmed rectovaginal endometriosis who underwent laparoscopic laser surgery between May 1999 and September 2006.Methods Women were identified from operative database, and a case note review was performed. Data for surgical outcome and surgical complications were collected.Main outcome measures Rates of urinary tract and colorectal complications.Results A total of 128 women underwent surgery. Of these, 32 required intraoperative closure of a rectal wall defect, including 3 segmental rectosigmoid resections. There were three rectovaginal fistulae and one ureterovaginal fistula. Ureteric damage occurred in two women, and five women suffered postoperative urinary retention. The risk of intraoperative bowel intervention was increased in women who complained of cyclical rectal bleeding.Conclusion Laparoscopic laser excision of rectovaginal endometriosis is a safe procedure with similar, if not lower, complication rates to other published surgical series.